2025-05-02 09:07:17
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Titan Biotech Ltd Q4 FY2023 consolidated net profit higher at Rs. 5.01 crore
Posted On : 2023-05-29 23:45:49( TIMEZONE : IST )
TITAN BIOTECH LTD. has reported Consolidated financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 37.3283 crores during the period ended March 31, 2023 as compared to Rs. 30.6115 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. 5.0134 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 3.2616 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. 6.07 for the period ended March 31, 2023 as compared to Rs. 3.95 for the period ended December 31, 2022.
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹37.3283 crs | ₹30.6115 crs |  21.94% |
| Net Profit | ₹5.0134 crs | ₹3.2616 crs | 53.71% |
| EPS | ₹6.07 | ₹3.95 | 53.67% |
Financial Results (Q4 FY2023) - YoY Comparison
The company has reported total income of Rs.37.3283 crores during the period ended March 31, 2023 as compared to Rs.33.33 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.5.0134 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.4.9870 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.6.07 for the period ended March 31, 2023 as compared to Rs.6.03 for the period ended March 31, 2022.
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹37.3283 crs | ₹33.33 crs | 12.00% |
| Net Profit | ₹5.0134 crs | ₹4.9870 crs | 0.53% |
| EPS | ₹6.07 | ₹6.03 | 0.66% |
Financial Results (Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.145.9426 crores during the Financial Year ended March 31, 2023 as compared to Rs.153.8322 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.24.8442 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.25.3330 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.30.06 for the Financial Year ended March 31, 2023 as compared to Rs.30.66 for the Financial Year ended March 31, 2022.
| Financials | Year Ended FY2023 | Year Ended FY2022 | % Change |
| Total Income | ₹145.9426 crs | ₹153.8322 crs |  -5.13% |
| Net Profit | ₹24.8442 crs | ₹25.3330 crs | -1.93% |
| EPS | ₹30.06 | ₹30.66 | -1.96% |
Shares of TITAN BIOTECH LTD. was last trading in BSE at Rs. 249.85 as compared to the previous close of Rs. 244.65. The total number of shares traded during the day was 12610 in over 260 trades.
The stock hit an intraday high of Rs. 254.00 and intraday low of 240.25. The net turnover during the day was Rs. 3145114.00.
